Metric Finance
LearnFAQ
LearnFAQ

Learn / PRAX

NASDAQ: PRAX

Praxis Precision Medicines (PRAX) stock, explained like you're 5

Praxis Precision Medicines trades on the Nasdaq under the ticker PRAX. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 7.3 billion dollars.

Ticker
PRAX
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Mid cap, about 7.3 billion dollars

Is Praxis Precision Medicines a small, medium or large cap company?

No. Praxis Precision Medicines is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 7.3 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Praxis Precision Medicines makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves PRAX stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Is Praxis Precision Medicines (PRAX) Priced Too Highly On Book Value? (Yahoo Finance)
  • Praxis Precision Medicines Slides as Investors Weigh Earlier Trial Miss and Upcoming FDA Decisions (Quiver Quantitative)
  • Responsive Playbooks and the PRAX Inflection (Stock Traders Daily)
  • Fourteen new employees receive Praxis stock awards covering 3,478 shares. (Stock Titan)
  • These Two Stocks Hit Fresh 52 Week Highs Today DCTH Clocks Best Day In Nearly 15 Months (Stocktwits)

Follow PRAX in your daily brief

Each trading day at 5 PM ET we post what happened to Praxis Precision Medicines and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow PRAX

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Praxis Precision Medicines stock

What does Praxis Precision Medicines do?

Praxis Precision Medicines trades on the Nasdaq under the ticker PRAX. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 7.3 billion dollars.

What is the ticker symbol for Praxis Precision Medicines?

Praxis Precision Medicines trades under the ticker PRAX on the Nasdaq.

What is Praxis Precision Medicines's market cap?

Praxis Precision Medicines is a mid cap stock with a market cap of about 7.3 billion dollars.

How does Praxis Precision Medicines make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves PRAX stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow PRAX stock every day?

Add PRAX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow PRAX daily

A free brief on Praxis Precision Medicines and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare PRAX: PRAX vs NVS, PRAX vs AZN, PRAX vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed